Evaluation of common profibrotic pathway across interstitial lung disease. Evaluation of common profibrotic pathway across interstitial lung disease

Given that the etiology and clinical manifestations differ substantially between IPF and SSc-ILD, we sought to better understand the similarities and differences in various profibrotic pathways of interest. Overall design: RNA-seq was performed on lung samples collected from IPF and SSc-ILD patients undergoing transplantation.